| Literature DB >> 28105060 |
Samihah Zura Mohd Nani1, F A A Majid2, A B Jaafar3, A Mahdzir4, M N Musa5.
Abstract
Deep sea water (DSW) commonly refers to a body of seawater that is pumped up from a depth of over 200 m. It is usually associated with the following characteristics: low temperature, high purity, and being rich with nutrients, namely, beneficial elements, which include magnesium, calcium, potassium, chromium, selenium, zinc, and vanadium. Less photosynthesis of plant planktons, consumption of nutrients, and organic decomposition have caused lots of nutrients to remain there. Due to this, DSW has potential to become a good source for health. Research has proven that DSW can help overcome health problems especially related to lifestyle-associated diseases such as cardiovascular disease, diabetes, obesity, cancer, and skin problems. This paper reviews the potential health benefits of DSW by referring to the findings from previous researches.Entities:
Year: 2016 PMID: 28105060 PMCID: PMC5221345 DOI: 10.1155/2016/6520475
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Total amount of elements in deep sea water [8].
| Element | Total (106 ton) |
|---|---|
| CI | 26,120,000,000 |
| Na | 14,550,000,000 |
| Mg | 1,728,000,000 |
| S | 1,312,000,000 |
| Ca | 556,000,000 |
| K | 538,000,000 |
| Br | 90,000,000 |
| C | 36,000,000 |
| N | 11,700,000 |
| Sr | 10,500,000 |
| B | 6,100,000 |
| O | 3,800,000 |
| Si | 3,800,000 |
| F | 1,900,000 |
| Ar | 840,000 |
| Li | 240,000 |
| Rb | 160,000 |
| P | 84,000 |
| I | 78,000 |
| Ba | 20,000 |
| Mo | 14,000 |
| U | 4,300 |
| V | 2,700 |
| As | 1,600 |
| Ni | 650 |
| Zn | 470 |
| Kr | 420 |
| Cs | 413 |
| Cr | 271 |
| Sb | 270 |
| Ne | 216 |
| Se | 209 |
| Cu | 202 |
| Cd | 94 |
| Xe | 89 |
| Fe | 40 |
| Al | 40 |
| Mg | 27 |
| Y | 22 |
| Zr | 20 |
| TI | 17 |
| W | 13 |
| Re | 11 |
| He | 10 |
| Ti | 8.8 |
| La | 7.6 |
| Ge | 2.4 |
| Nb | <7 |
| Hf | 4.6 |
| Nd | 4.4 |
| Ta | <3 |
| Ag | 2.7 |
| Co | 1.6 |
| Ga | 1.6 |
| Er | 1.6 |
| Yb | 1.6 |
| Dy | 1.5 |
| Gd | 1.2 |
| Pr | 0.9 |
| Ce | 0.9 |
| Se | 0.9 |
| Sm | 0.8 |
| Sn | 0.7 |
| Ho | 0.5 |
| Lu | 0.3 |
| Be | 0.3 |
| Tm | 0.3 |
| Eu | 0.2 |
| Hg | 0.2 |
| Rh | 0.1 |
| Te | 0.1 |
| Pd | 0.008 |
| Pt | 0.07 |
| Bi | 0.04 |
| Au | 0.03 |
| Th | 0.02 |
| In | 0.01 |
| Ru | <0.006 |
| Os | 0.003 |
| Ir | 0.0002 |
Amount of elements in the surface seawater and deep sea water [6].
| Type of element | Surface seawater (mg/L) | Deep sea water (mg/L) |
|---|---|---|
| Na | 10800 | 7240 |
| K | 392 | 10400 |
| Ca | 411 | 39 |
| Mg | 1290 | 96100 |
| Sr | 8.1 | 0.17 |
| B | 4.45 | 320 |
| Fe | 0.003 | 0.25 |
| Li | 0.17 | 11.7 |
| Cu | 0.0009 | 0.22 |
| Co | 0.0004 | 0.26 |
| Mo | 0.01 | 0.62 |
| Ni | 0.0066 | 0.11 |
| Cr | 0.0002 | 0.087 |
| Rb | 0.12 | 1.2 |
| Si | 2.9 | 0.5 |
| V | 0.002 | 1.2 |
| F | 13 | 21.8 |
| Br | 67.3 | 5400 |
| I | 0.064 | 5.5 |
Effects of deep sea water on cholesterol levels.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | High fat diet (HFD) male Wistar rats (200–220 g), DSW 1,000 hardness, ad libitum, 4 weeks | Increased the level of HDL-C. | ND. | [ |
|
| ||||
| In vivo study | Cholesterol-fed diet (CFD) male New Zealand white rabbits (1500–2000 g) fed diet containing 3.75, 37.5, and 75 mg/kg of Mg, DSW 1410 hardness, 8 weeks | Improved plasma total cholesterol (TC), triglyceride (TG), and LDL-C levels. | Improved the protein expression of AMPK phosphorylation, ACC phosphorylation, and HMGCR. | [ |
|
| ||||
| In vivo study | High cholesterol diet (HCD) ICR mice (7 weeks), reverse osmosis (RO DSW) (44.6 hardness), electrodialysis (ED DSW) (4685.9 hardness) and 10% (v/v) dilution with ddH2O 10% DSW (544.2 hardness), ad libitum, 8 weeks | Reduced the level of TG, TC, and non-high-density lipoprotein cholesterol (non-HDL-C) levels in the serum and liver of animal models, respectively. | Increase in daily faecal lipid of TG and TC and bile acid outputs. | [ |
| HFD Hamster (5 weeks), DSW 300, 900, 1500 hardness, ad libitum, 6 weeks | Increase in daily faecal lipid of TG and TC and bile acid outputs. | [ | ||
|
| ||||
| Type of study model | Male hyperlipidemia rabbits (1.8–2.0 g), DSW 1200 hardness, 150 ml/d, ad libitum, 12 weeks | Reduced plasma TC and plasma LDL cholesterol level. | ND. | [ |
|
| ||||
| In vivo study | Male Wistar rats (90 g), DSW containing 200, 600, and 1000 mg/L of Mg, ad libitum, 4 weeks | Attenuated plasma TC. | ND. | [ |
|
| ||||
| Clinical study | Hypercholesterolemic individuals (23 men and 19 women), DSW (1410 hardness), supplemented 1050 mL daily, 6 weeks | Decreased serum TC and low-density lipoprotein cholesterol (LDL-C). | Decreased lipid peroxidation in hypercholesterolemic subjects. | [ |
|
| ||||
| Clinical study | CFD and hyperlipemia male Japanese rabbits, DSW hardness of 28, 300, and 1200, 150 ml/d, ad libitum, 4 weeks | Reduced TC and LDL-C levels in hyperlipemia rabbits. | ND. | [ |
ND: not described.
Effects of deep sea water on cardiovascular protection.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | HCD ICR mice (7 weeks), reverse osmosis-DSW 44.6 hardness, Electrodialysis-DSW 4685.9 hardness, 10% DSW 544.2 hardness, 8 weeks | Reduced abnormal cardiac architecture, apoptosis in left ventricle (LV). | Decreased LV diameter, LV thickness, and ratio of thickness to diameter in hearts. | [ |
|
| ||||
| In vivo study | High fat/cholesterol-fed (HFCD) male Syrian Golden hamster (5 weeks), DSW 300, 900, and 1500 hardness, ad libitum, 6 weeks | Decreased levels of serum TC, TG, atherogenic index, and malondialdehyde. | Increase in daily faecal lipid of TG and TC and bile acid outputs. | [ |
|
| ||||
| In vivo study | Kurosawa and Kusanagi-Hypercholesterolemic (KHC) rabbits (4 months), DSW 1000 hardness, 500 ml/d, 6 months | Improved cardiovascular hemodynamics. | Lowered systolic, diastolic pulse, mean arterial pressures, and total peripheral resistance. | [ |
Effects of deep sea water on atherosclerosis.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | CFD male New Zealand white rabbits (1500–2000 g) fed diet contain 3.75, 37.5, and 75 mg/kg of Mg, DSW 1410 hardness, 8 weeks | Reduced serum lipids, prevented atherogenesis, and suppressed serum cholesterol levels. | Improved protein expression of AMPK phosphorylation, ACC phosphorylation, and HMGCR. | [ |
|
| ||||
| In vivo study | Male hyperlipidemia rabbits (1.8–2.0 g), DSW 1200 hardness, 150 ml/d, ad libitum, 12 weeks | Suppressed lipid deposition on the inner wall of the aorta. Suppressed foam cell formation. | Reduced plasma TC, plasma LDL cholesterol, and LPO. | [ |
|
| ||||
| In vivo study | CFD and hyperlipemia male Japanese rabbits, DSW hardness of 28, 300, and 1200, 150 ml/d, 4 weeks | Reduced TC and LDL-C levels in hyperlipemia rabbits. | ND. | [ |
ND: not described.
Effects of deep sea water on blood pressure.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | Spontaneous hypertensive rats (250–300 g) fed diet containing 3.75, 37.5, and 75 mg/kg of Mg, DSW 1410 hardness, ad libitum, 8 weeks | Decreased blood pressure. | Decreased systolic and diastolic pressure. | [ |
|
| ||||
| In vivo study | Kurosawa and Kusanagi-Hypercholesterolemic (KHC) rabbits (4 months), DSW 1000 hardness, 500 ml/d, 6 months | Decreased blood pressure. | Lowered systolic, diastolic pulse, and mean arterial pressure and total peripheral resistance. | [ |
Effects of deep sea water on obesity.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vitro study | C2C12 cells, DSW 100, 500, 1000, 1500, and 2000 hardness, indicated time of 0, 1, 2, and 3 days | Increased mitochondrial biogenesis and function. | Enhanced gene expression of peroxisome proliferator-activated receptor gamma coactivator 1 | [ |
|
| ||||
| In vitro study | 3T3-L1 cells, DSW 100, 500, and 1000 hardness, 3 days | Decreased lipid accumulation. | Reduced expression mRNA levels of PPAR | [ |
|
| ||||
| In vivo study | HFD C57BL/6J mice (6 weeks), DSW 500, 1000, and 2000 hardness, ad libitum, 20 weeks | Enhanced mitochondrial biogenesis in muscles. | Improved mitochondrial DNA (mtDNA) content in the muscles of HFD-induced obese mice. | [ |
|
| ||||
| In vivo study | HFD C57BL/6J mice (6–26 weeks), DSW 500, 1000, and 2000 hardness, ad libitum, 20 weeks | Suppressed body weight gain. | Suppressed mRNA expression of key adipogenic genes such as PPAR | [ |
|
| ||||
| In vivo study | Male C57BL/6J ob/ob mice, DSW 1000 hardness, ad libitum, 84 days | Decreased body weight gain by 7%. | Increased glucose disposal. | [ |
Effects of deep sea water on diabetes.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vitro study | Differentiated C2C12 cells, DSW 100, 500, 1000, 1500, and 2000 hardness, 1 hr | Increased glucose uptake. | Stimulated the phosphorylation of IRS-1, LKB1, AMPK, and mTOR and improved impaired phosphorylation of these molecules. | [ |
|
| ||||
| In vitro study | Matured 3T3-L1 cells, DSW 500, 1000, and 2000 hardness, 1 hr | Increased glucose uptake. | Increased AMPK phosphorylation in 3T3-L1 pre- and mature adipocytes. | [ |
|
| ||||
| In vivo study | Streptozotocin- (STZ-) induced diabetic male ICR mice (4–9 weeks), DSW 1000, 2000, and 4000 hardness, ad libitum, 4 weeks | Improved impaired glucose tolerance. | Increased adiponectin and leptin levels and reduced the levels of the proinflammatory cytokines IL-6 and TNF- | [ |
|
| ||||
| In vivo study | HFD-induced diabetic male C57BL/6J mice (6–25 weeks), DSW 500, 1000, and 2000 hardness, ad libitum, 20 weeks | Improved impaired glucose tolerance. | Recovered size of the pancreatic islets of Langerhans and increased the secretion of insulin and glucagon. | [ |
|
| ||||
| In vivo study | Male C57BL/6J ob/ob mice, DSW 1000 hardness, ad libitum, 84 days | Reduced glucose levels in plasma by 35.4%. | Increased glucose disposal. | [ |
Effects of deep sea water on skin diseases.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | Male NC/Nga mice (6 weeks), 2% concentrated DSW (CDSW) (7958.6 hardness), 10% CDSW (39793 hardness), 200 | Reduced severity of symptoms in the skin lesions, such as edema, erythema, dryness, itching, and transepidermal water loss (TEWL). | Inhibited upregulation of IgE, histamine, and proinflammatory cytokines (TNF- | [ |
|
| ||||
| Clinical study | 33 patients (mean age 26 years, range 1–50 years, 13 male and 20 female subjects), DSW 1000 hardness, 500 ml/day, 6 months | Improved skin symptoms. | Improved skin symptoms such as inflammation, lichenification, and cracking in skin. | [ |
|
| ||||
| Clinical study | 50 patients with allergic rhinitis (age 22–50 years), DSW 1000 hardness, 500 ml/day, 3 weeks | Improved skin symptoms. | Reduced allergic skin responses and serum levels of total IgE, Japanese cedar pollen-specific IgE, IL-4, IL-6, IL-13, and IL-18. | [ |
Effects of Deep Sea Water on Hepatic Protection.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vitro study | HepG2 cells, DSW 200, 400, 600, 800, and 1000 hardness, 24 hr | Decreased lipids accumulation. | Inhibited the activity of HMGCR by 30.2%. | [ |
|
| ||||
| In vivo study | HFD male Wistar rats (200–220 g), DSW 1,000 hardness, ad libitum, 4 weeks | Decreased levels of TC and TG in liver. | Decreased serum levels of AST and ALT. | [ |
|
| ||||
| In vivo study | HFD C57BL/6J mice (6–26 weeks), DSW 500, 1000, and 2000 hardness, ad libitum, 20 weeks | Suppressed the expression of genes involved in lipogenesis and cholesterol synthesis; and increased the expression of genes related to b-oxidation in liver. | Decreased the expression of Fas and acetyl-CoA carboxylase 1 (ACC1), which are involved in lipogenesis, and liver X receptor a (LXR a), and 5-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoAR), which are involved in cholesterol metabolism. | [ |
|
| ||||
| In vivo study | HFD male Golden Syrian hamsters (5 weeks), DSW 300, 900, and 1500 hardness, ad libitum, 6 weeks | Decreased lipids accumulation in liver. | Increased daily faecal lipid and bile acid outputs. | [ |
Effects of deep sea water on fatigue.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | Exercise-induced fatigue male Wistar rats, DSW 100, and 600 hardness, dosages (6, 12, and 30 mL/kg·d) | Promoted the endurance of rats in exercise test. | Improved the ratio of lactic acid elimination to lactic acid increment. | [ |
|
| ||||
| Clinical study | 12 healthy male volunteers (age 24 ± 0.8 years; height 171.8 ± 1.5 cm; weight 68.2 ± 2.3 kg; VO2max 49.7 ± 2.2 ml·kg−1·min−1), randomized, double-blind, placebo-controlled, DSW 710 hardness, fatiguing exercise conducted for 4 hr at 30°C | Accelerated recovery from physical fatigue. | Complete recovery of aerobic power within 4 hr. | [ |
Effects of deep sea water on stomach ulcer.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | Female Wistar rats (220–250 g weight), DSW 600 (41 mL/day), DSW 1200 (39 mL/day), 1 week | Reduced ulcer area as well as apoptotic signalling in acetic acid-induced duodenal ulcers. | Increased pH value, scavenging H2O2, and HOCl activity and reduced ORP value. | [ |
Effects of deep sea water on cancer.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Reference |
|---|---|---|---|
| In vitro study | MDA-MB-231 cells, DSW 200, 400, 800, and 1500 hardness, 2-3 days | Inhibited cells' migratory ability in a wound-healing assay, mediated through TGF- | [ |
|
| |||
| In vitro study | Noninvasive MCF-7 cells, DSW 200, 400, 800, and 1500 hardness, 2-3 days | Inhibited TPA-induced migration and MMP-9 activity with a concomitant decrease in mRNA levels of MMP-9, TGF- | [ |
|
| |||
| Green tea leaves were soaked in desalinated DSW at 75°C for 10 min | Increased nitrite scavenging activity from 31.33 ± 0.05 to 37.12 ± 0.42%. | [ | |
|
| |||
|
| 71.4% inhibitory effect on the mutagenesis induced by 4NQO against TA98 strain. | [ | |
Effects of deep sea water on cataract.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | Male Shumiya cataract rat (5–15 weeks), DSW (Mg2+, 200 mg/L, Ca2+; 71 mg/L), 9-10 weeks | Delayed cataract development. | Reduced less opaque and nitric oxide (NO) levels. | [ |
|
| ||||
| In vivo study | Male Shumiya cataract rat (5–15 weeks), DSW containing Mg of 50, 200, and 1000 mg/L, respectively, 9-10 weeks | Delayed cataract onset. | Mg suppressed Ca influx into the lens. | [ |
Effects of deep sea water on antibacterial activity.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Reference |
|---|---|---|---|
| In vitro study | Five types ratio of DSW containing magnesium : calcium (Mg : Ca) ratios of 1 : 2 (A), 1 : 1 (B), 3 : 1 (C), 1 : 0 (D), and 0 : 1 (E) at different concentrations to give levels of hardness of 100, 250, 500, and 1000; produced 20 types of samples | Inhibited bacterial growth and mobility. | [ |
|
| |||
| In vitro study | Sheep blood, | DSW hardness of 1200 and 2400 inhibited growth of | [ |
|
| |||
| In vivo study | Male Mongolian gerbils (4 weeks), DSW at 5 different Mg/Ca ratios (hardness of 1000) were administered for 2 weeks | Decreased amount of | [ |
|
| |||
| Clinical study | Healthy subjects infected with | Reduced Δ13 C values. | [ |
Effects of deep sea water on osteoporosis.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Reference |
|---|---|---|---|
| In vitro study | Osteoblastic cell (MC3T3), DSW 50, 1000, and 2000 hardness, 3 days | Increased cells proliferation. | [ |
|
| |||
| In vitro study | Bone marrow stromal cells (BMSCs), DSW 1000 hardness, 3 days | Enhanced colony forming abilities. | [ |
|
| |||
| In vivo study | Ovariectomized (OVX) SAMP8 mice (4 months), DSW 1000 hardness, 5.2 mL/day, 4 months | Enhanced bone mineral density. | [ |
Effects of deep sea water in the liver and kidney status.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Reference |
|---|---|---|---|
| In vivo study | HFD male Wistar rats (200–220 g), DSW 1,000 hardness, ad libitum, 4 weeks | Improved liver function by the decrease of serum levels of AST and ALT. | [ |
|
| |||
| In vivo study | HFD male Golden Syrian hamsters (5 weeks), DSW 300, 900, and 1500 hardness, ad libitum, 6 weeks | Attenuated serum AST values in hamsters drinking DSW 300, 900, and 1500. | [ |
|
| |||
| In vivo study | CFD male New Zealand white rabbits (1500–2000 g) fed diet containing 3.75, 37.5, and 75 mg/kg of Mg, DSW 1410 hardness, 8 weeks | No differences were observed in values of AST and ALT. | [ |
|
| |||
| In vivo study | Male hyperlipidemia rabbits (1.8–2.0 g), DSW 1200 hardness, 150 ml/d, ad libitum, 12 weeks | No differences were observed in values of AST and ALT. | [ |
|
| |||
| Clinical study | Hypercholesterolemic individuals (23 men and 19 women), DSW (1410 hardness), supplemented 1050 mL daily, 6 weeks | No significant difference of ALT, AST, and BUN levels between treated subjects and controls. | [ |
Effects of functional deep sea water with other substances.
| Type of study model | Experimental method [subject (age/weight), treatment dosage, duration of treatment] | Major activity | Mechanism of action | Reference |
|---|---|---|---|---|
| In vivo study | Outbred albino female ICR mice (20–26 g), yogurt containing DSW, 10.3 g hardness of CaCO3/L, 8 weeks | Increased populations of intestinal lactic acid bacteria. | ND. | [ |
|
| ||||
| In vivo study | HFD-induced obesity ICR (4 weeks), DSW, and DSW + 125 mg/kg SIE (DSS), ad libitum, treated with SIE once per day for 8 weeks | Reduced body weights in the DSW group by 3.95% and in the DSS group by 8.42%, respectively. | Decreased size of the epididymal white, retroperitoneal white, and scapular brown adipose tissue. | [ |
|
| ||||
| In vivo study | Green tea leaves were soaked in desalinated DSW at 75°C for 10 min | Increased antioxidant activity. | Increased 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities by 83.98% and increased reducing power by 15%. | [ |
ND: not described.